Genprex, Inc is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options.
What they will learn from this webinar
- How Genprex is bridging critical gaps in modern medicine by providing new treatment options to patients with cancer and diabetes
- The Company’s oncology program and its modern combinational treatment approach to fight cancer
- How its diabetes program could eliminate the need for insulin in diabetic patients
At Genprex, they believe their therapies offer a strong value proposition to the market to address unmet medical needs and save lives.